Experience

Davis Polk advised the initial purchasers in connection with a $600 million 5.25% Regulation S additional senior notes offering by Fortune Star (BVI) Limited, a wholly owned subsidiary of…

Davis Polk advised the joint lead managers in connection with the reopening of the Hashemite Kingdom of Jordan’s 6.125% notes due 2026 in the aggregate principal amount of $500 million…

Davis Polk advised the joint book-running managers in connection with the $225 million initial public offering of 15,000,000 shares of Class A common stock of Carvana Co. The Class A common…

Davis Polk advised The Orogen Group on its $108 million strategic equity investment in newly issued convertible preferred stock of Virtusa Corporation. In connection with the investment,…

Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Flexion Therapeutics, Inc. of $201.25 million aggregate principal amount of its 3.375% convertible…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €3.5 billion aggregate principal amount of senior notes, consisting of €1.5 billion floating-rate…

Davis Polk advised Uniti Group Inc. in connection with an underwritten public offering of 19,528,302 shares of its common stock. Uniti intends to use the net proceeds from the offering to…

Davis Polk advised Murphy USA Inc. in connection with an SEC-registered offering of $300 million aggregate principal amount of 5.625% senior notes due 2027. The notes were issued by Murphy…

Davis Polk is advising Tyson Foods, Inc. on its approximately $4.2 billion acquisition of AdvancePierre Foods Holdings, Inc. The transaction, which is expected to close in the third quarter…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 5,050,505 shares of common stock of…